A Methodological Evaluation of Dosimetry Studies in Mammography
Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi · 31.05.2026 · 16 (2) · 314-315
DOI: 10.31020/mutftd.1868385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi, online erschienen am 31.05.2026. Verfasst von Gökçe Kaan Ataç.
Abstract (Originalsprache)
This letter provides a scientific critique and methodological evaluation of a recent article published in Lokman Hekim Health Sciences regarding typical dose levels in mammography. It is emphasized that defining the data within the framework of ICRP Publication 135 as "Local Typical Values" would enhance terminological precision. The text offers constructive suggestions such as integrating on-site physical measurements (HVL and tube output) into dose calculations, establishing correlations with the equipment's own Radiation Dose Structured Reports (RDSR), and aligning glandularity assumptions for older populations (using 25% instead of a fixed 50%) with clinical reality. It is evaluated that these refinements would increase the sensitivity of calculated dose data and provide a more robust foundation for radiation dose optimization processes.
Zitieren
APA
Ataç, G. K. (2026). A Methodological Evaluation of Dosimetry Studies in Mammography. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi, 16(2), 314-315. https://doi.org/10.31020/mutftd.1868385
Vancouver
Ataç GK. A Methodological Evaluation of Dosimetry Studies in Mammography. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi. 2026;16(2):314-315. doi:10.31020/mutftd.1868385
BibTeX
@article{Ata2026,
author = {Ataç, Gökçe Kaan},
title = {A Methodological Evaluation of Dosimetry Studies in Mammography},
journal = {Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi},
year = {2026},
volume = {16},
number = {2},
pages = {314--315},
doi = {10.31020/mutftd.1868385}
}
EUVIMED